Pharmacological Treatment of Patients with Mild to Moderate COVID-19: A Comprehensive Review

Mild to moderate COVID-19 can be found in about 80% of patients. Although mortality is low, mild to moderate COVID-19 may progress to severe or even critical stages in about one week. This poses a substantial burden on the health care system, and ultimately culminates in death or incapacitation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bestetti, Reinaldo B., Furlan-Daniel, Rosemary, Silva, Vinicius M. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297311/
https://www.ncbi.nlm.nih.gov/pubmed/34281149
http://dx.doi.org/10.3390/ijerph18137212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297311/
https://www.ncbi.nlm.nih.gov/pubmed/34281149
http://dx.doi.org/10.3390/ijerph18137212

Ejemplares similares